BFS
TEVA icon

Baskin Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History

Baskin Financial Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-810
Closed -$26K – 48
2017
Q1 		$26K Sell
810
-90,745
-99% -$3.1M 0.01% 46
2016
Q4 		$3.32M Sell
91,555
-2,758
-3% -$110K 0.82% 37
2016
Q3 		$4.34M Buy
94,313
+2,618
+3% +$137K 1.14% 34
2016
Q2 		$4.6M Buy
91,695
+1,275
+1% +$67.9K 1.3% 33
2016
Q1 		$4.84M Buy
90,420
+2,560
+3% +$150K 1.4% 33
2015
Q4 		$5.76M Buy
87,860
+1,100
+1% +$68K 1.78% 30
2015
Q3 		$4.9M Sell
86,760
-1,475
-2% -$95.6K 1.66% 32
2015
Q2 		$5.21M Buy
88,235
+1,550
+2% +$95.6K 1.63% 33
2015
Q1 		$5.4M Buy
86,685
+3,365
+4% +$196K 1.8% 32
2014
Q4 		$4.79M Buy
83,320
+1,775
+2% +$98.9K 1.55% 34
2014
Q3 		$4.38M Buy
81,545
+850
+1% +$45K 1.52% 33
2014
Q2 		$4.23M Buy
80,695
+5,175
+7% +$265K 1.47% 33
2014
Q1 		$3.99M Buy
75,520
+175
+0.2% +$8.09K 1.53% 33
2013
Q4 		$3.02M Sell
75,345
-2,825
-4% -$111K 1.22% 32
2013
Q3 		$2.95M Buy
78,170
+8,000
+11% +$312K 1.41% 30
2013
Q2 		$2.74M Buy
+70,170
New +$2.73M 1.51% 30

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baskin Financial Services's TEVA Position: Q2 2017 in Review

Baskin Financial Services sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 810 shares — an estimated $26K sold.

Baskin Financial Services first reported a position in TEVA in Q2 2013 and held it in 16 quarters. The position peaked at $5.76M in Q4 2015. 649 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • Baskin Financial Services reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Baskin Financial Services sold 810 Teva Pharmaceuticals shares in Q2 2017, an estimated $26K.
  • Baskin Financial Services first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 16 quarters.
  • Baskin Financial Services's Teva Pharmaceuticals position peaked at $5.76M in Q4 2015.
  • 649 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Baskin Financial Services's 13F filing for Q2 2017, filed 25 Jul 2017.